Related Experiment Video
Updated: Aug 30, 2025

Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis
Published on: July 11, 2019
Development of Central Venous Stenosis Upon ICD Implantation in Dialysis Patients: A Non-Negligible Issue
Rohit J Timal1, Ioannis Karalis1, Jose M Montero Cabezas1
1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Insights
Central venous stenosis (CVS) affects over 40% of hemodialysis patients after implantable cardioverter-defibrillator (ICD) implantation. Further research is needed to prevent these complications in dialysis patients with cardiac devices.
Area of Science:
- Cardiology
- Nephrology
- Vascular Medicine
Background:
- Implantable cardioverter-defibrillator (ICD) implantation in hemodialysis patients can lead to central venous stenosis (CVS).
- Symptoms of CVS include pain, edema, and loss of dialysis access.
- Literature on CVS in dialysis patients with cardiac implantable electronic devices is limited.
Purpose of the Study:
- To investigate the incidence of central venous stenosis (CVS) in end-stage renal disease patients on chronic dialysis who received an ICD.
- To assess the relationship between ICD implantation and the development of CVS.
Main Methods:
- Prospective cohort study within the randomized ICD2 trial.
- 80 dialysis patients received an ICD between 2007 and 2017.
- Venography performed pre-ICD and at 1-year follow-up; clinical follow-up for symptoms.
Main Results:
- 33.9% of patients (19/56) showed partial central vein obstruction, and 7.1% (4/56) had complete occlusion at 1 year.
- Median follow-up was 16 months for venography and 3.5 years for clinical assessment.
- Only 3 patients developed clinically significant CVS symptoms.
Conclusions:
- Central venous stenosis (CVS) is a significant concern in dialysis patients following ICD implantation.
- The findings highlight the need for preventative strategies and further research.
- Monitoring central vein patency is crucial in this patient population.
Background:
In hemodialysis patients, implantable cardioverter-defibrillator (ICD) implantation may result in central venous stenosis (CVS) with associated symptoms, such as pain, edema of the ipsilateral arm, facial edema, and loss of dialysis access. However, literature concerning CVS in dialysis patients with a cardiac implantable electronic device is scarce.
Methods:
We conducted a prospective cohort study in which we investigated the incidence of CVS in end-stage renal disease patients on chronic dialysis who received an ICD as part of participation in the randomized ICD2 trial. A venography was performed before ICD implantation and at 1 year follow-up.
Results:
Between 2007 and 2017, 80 patients on dialysis received an ICD according to ICD2 trial protocol. Our population mainly consisted of males (76.3%), and had a median age of 67 years. Hemodialysis was the predominant dialysis modality (71.3%). The ICD was implanted in the right pectoral region in 58 patients (72.5%). A minority of the patients (27.5%) had a history of central venous catheters use, ipsilateral to ICD implantation site. Median follow-up was 16 months (IQR 13-35). Prospective assessment of central vein patency was possible in 56 patients (70.0%). Partial obstruction of central vein at follow-up was present in 19 out of 56 patients (33.9%) and complete occlusion in 4 patients (7.1%). With a complete clinical follow-up of all patients with a median duration of 3.5 years (IQR 2.7 - 6.3), 3 patients developed clinically significant symptoms of CVS.
Conclusions:
Development of CVS in patients on chronic dialysis who received an ICD is a cause of concern. Prevention of such complications deserves attention and further research.
Trial Registration:
ISRCTN20479861.
More Related Videos
Related Concept Videos
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis I: Introduction
Endocarditis IV: Nursing Management
Hemodialysis III: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview

